Injection Safety


Promoting Safer Immunization


Syringe reuse has been linked to transmission of hepatitis B and C viruses, HIV, malaria.

In 1999, WHO and UNICEF began to address the spread of blood borne diseases through reuse of needles and syringes by recommending that auto-disable (AD) syringes be used for all immunizations. Since their introduction in the mid-1990s, AD syringes have been widely accepted and are now used to administer immunizations globally.

View BD immunization highlights (PDF)

What to look for when procuring Auto-Disable (AD) Syringes
Download Report (PDF) »

BD UniJect Device

BD Uniject™ Auto-Disable Device

In collaboration with USAID, WHO, and many others, PATH
developed an auto-disable, prefilled, single-use device known as the Uniject™* device. Today, both TT and hepatitis B vaccine are available in the Uniject device.

The BD Uniject device simplifies the act of giving an injection, makes the unsafe reuse of the syringe impossible, and reduces the burden on logistics systems by making medicament, needle, and syringe available at the same place and time.

The device also helps eliminate the waste commonly associated with multidose vials. Today, the Uniject device is licensed to BD for commercial production and distribution.

BD SoloShot Syringes

 

BD SoloShot™ and BD SoloShot™ Mini Auto-Disable Syringes

Where multidose vials and syringes are indicated, BD SoloShot™  auto-disable syringes are ideal for large-scale immunization programs.

Easy to use

Designed with minimal dead space to reduce medication waste
The same quality and dependability that you’ve come to expect from BD for both Intramuscular and Intradermal injections
Meet ISO 7886-4 Type 1B requirements for passive reuse prevention

BD SoloMed Syringe

 

BD SoloMed™ Syringe

The BD SoloMed™ syringe is intended for acute care facilities in
developing countries.
An extra push after use breaks the plunger, preventing reuse.
BD also offers a safety-shielded version.

BD Emerald PRO Syringe

 

BD Emerald™ PRO

Reuse prevention syringe with a passive locking mechanism.

Meets ISO 7886-4 Type 1B requirements for passive reuse prevention

Available in various sizes to accommodate both injection and reconstitution needs

 

MSS0168   07/2012

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2013 BD